Clinical Trials Logo

Anal Cancer Stage III clinical trials

View clinical trials related to Anal Cancer Stage III.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04230759 Active, not recruiting - Anal Cancer Clinical Trials

Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. A Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

RADIANCE
Start date: January 7, 2020
Phase: Phase 2
Study type: Interventional

The RADIANCE multicenter, randomized phase II trial will assess the efficacy of durvalumab, a PD-L1 immune checkpoint inhibitor, in combination with primary mitomycin C (MMC)/5-fluorouracil (5-FU)-based radiochemotherapy (RCT) in patients with locally-advanced anal squamous cell carcinoma (ASCC).